Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 1/20 | 0.72 |
| ▸ | TP53 | P04637 | 1/20 | 0.55 |
| ▸ | TBXAS1 | P24557 | 5/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | ESR1 | P03372 | 1/20 | 0.44 |
| ▸ | GLA | P06280 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | APEX1 | P27695 | 2/20 | 0.41 |
| ▸ | RXRA | P19793 | 1/20 | 0.40 |
| ▸ | RXRB | P28702 | 1/20 | 0.40 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.40 |
| ▸ | RXRG | P48443 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3414243 | 1.00 | AKR1C3 (0.72) | AKR1C3TP53TBXAS1PTGS2HTT | |
| SCHEMBL532625 | 0.94 | AKR1C3 (0.77) | AKR1C3TP53TBXAS1HTTPOLB | |
| SCHEMBL532624 | 0.94 | AKR1C3 (0.77) | AKR1C3TP53TBXAS1HTTPOLB | |
| SCHEMBL2462984 | 0.93 | AKR1C3 (0.82) | AKR1C3TP53TBXAS1HTTPOLB | |
| SCHEMBL2462983 | 0.93 | AKR1C3 (0.82) | AKR1C3TP53TBXAS1HTTPOLB | |
| SCHEMBL4806412 | 0.92 | AKR1C3 (0.62) | AKR1C3TP53TBXAS1PTGS2HTT | |
| SCHEMBL4805932 | 0.92 | AKR1C3 (0.62) | AKR1C3TP53TBXAS1PTGS2HTT | |
| SCHEMBL4808963 | 0.90 | AKR1C3 (0.60) | AKR1C3TP53TBXAS1HTTALDH1A1 | |
| SCHEMBL4801214 | 0.90 | AKR1C3 (0.60) | AKR1C3TP53TBXAS1PTGS2POLB | |
| SCHEMBL1842887 | 0.90 | AKR1C3 (0.60) | AKR1C3TP53PTGS2HTTPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110300919-B | Liquid crystal display device having a plurality of pixel electrodes | DIC株式会社 | 2022-07-01 | — | — | CN | disclosed |
| EP-3257916-B1 | LIQUID CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2021-11-17 | — | — | EP | disclosed |
| US-20210277310-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2021-09-09 | — | — | US | disclosed |
| CN-105814480-B | Liquid crystal display device having a plurality of pixel electrodes | DIC株式会社 | 2020-01-07 | — | — | CN | disclosed |
| US-20190113792-A1 | LIQUID CRYSTAL PANEL AND METHOD FOR MANUFACTURING LIQUID CRYSTAL PANEL | SHARP KABUSHIKI KAISHA (JP) | 2019-04-18 | — | — | US | disclosed |
| US-20180119010-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2018-05-03 | — | — | US | disclosed |
| US-9864236-B2 | Method for manufacturing liquid crystal display device | SHARP KABUSHIKI KAISHA (JP) | 2018-01-09 | — | — | US | disclosed |
| EP-3260518-A1 | LIQUID CRYSTALLINE MEDIUM | Merck Patent GmbH (DE) | 2017-12-27 | — | — | EP | disclosed |
| EP-3257916-A1 | LIQUID CRYSTALLINE MEDIUM | Merck Patent GmbH (DE) | 2017-12-20 | — | — | EP | disclosed |
| US-9817274-B2 | Method for manufacturing liquid crystal display device | SHARP KABUSHIKI KAISHA (JP) | 2017-11-14 | — | — | US | disclosed |
| US-20110255048-A1 | LIQUID-CRYSTAL DISPLAY | MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) | 2011-10-20 | — | — | US | disclosed |
| US-20100272925-A1 | LIQUID-CRYSTAL DISPLAY | MERCK PATENT GESELLSCHAFT (DE) | 2010-10-28 | — | — | US | disclosed |
| EP-2243812-A2 | Liquid crystal display | Merck Patent GmbH (DE) | 2010-10-27 | — | — | EP | disclosed |
| US-6982181-B2 | Manufacturing process for ultra slim electrooptic display device unit | SONY CORPORATION (JP) | 2006-01-03 | — | — | US | disclosed |
| US-20050266591-A1 | Manufacturing process for ultra slim electrooptic display device unit | SONY CORPORATION | 2005-12-01 | — | — | US | disclosed |
| US-6844905-B2 | Alignment film, method for fabricating the alignment film, liquid crystal device, and projection type display device | SEIKO EPSON CORPORATION (JP) | 2005-01-18 | — | — | US | disclosed |
| US-20040259326-A1 | Manufacturing process for ultra slim electrooptic display device unit | SONY CORPORATION (JP) | 2004-12-23 | — | — | US | disclosed |
| US-20040080685-A1 | Alignment film, method for fabricating the alignment film, liquid crystal device, and projection type display device | SEIKO EPSON CORPORATION (JP) | 2004-04-29 | — | — | US | disclosed |
| WO-2001087829-A1 | BISACYLGUANIDINE | MERCK PATENT GMBH (DE) | 2001-11-22 | — | — | WO | disclosed |
| US-4366171-A | Fungicidal biphenyl esters, mixtures thereof and method of use | GAF CORPORATION (US) | 1982-12-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110255048-A1 | LIQUID-CRYSTAL DISPLAY | KLK3, BPHL, LPXN | AKR1C3 3538/4885TP53 437/4885TBXAS1 3675/4885 |
| US-20100272925-A1 | LIQUID-CRYSTAL DISPLAY | KLK3, BPHL, LPXN | AKR1C3 2930/4885TP53 445/4885TBXAS1 3551/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.